These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10695496)

  • 1. Secondary prevention of stroke.
    MacWalter RS
    Thromb Haemost; 1999 Sep; 82 Suppl 1():95-103. PubMed ID: 10695496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent ischemic stroke.
    Dickerson LM; Carek PJ; Quattlebaum RG
    Am Fam Physician; 2007 Aug; 76(3):382-8. PubMed ID: 17708138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention.
    Hanley D; Gorelick PB; Elliott WJ; Broder MS; Saver JL; Kidwell CS; Fagan SC; Wilson A; Lennihan L; Schwer WA; Rubenstein LZ; Crowell RM; Haines SJ; Lopez CC; Zorowitz R; Dubois RW
    J Stroke Cerebrovasc Dis; 2004; 13(5):196-207. PubMed ID: 17903976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient ischaemic attacks and stroke.
    Hankey GJ
    Med J Aust; 2000 Apr; 172(8):394-400. PubMed ID: 10840494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):85-7. PubMed ID: 11010750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke risk factors and stroke prevention.
    Elkind MS; Sacco RL
    Semin Neurol; 1998; 18(4):429-40. PubMed ID: 9932614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention of stroke in the elderly: a review of the evidence.
    Alhusban A; Fagan SC
    Am J Geriatr Pharmacother; 2011 Jun; 9(3):143-52. PubMed ID: 21570361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
    Beckman JA
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S12-6. PubMed ID: 19530155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary stroke prevention].
    Ferro JM; Correia M; Freire A; Perez y Sanchez J; Abrunhosa MA; Perez y Sanchez MF
    Acta Med Port; 1998 Nov; 11(11):1019-40. PubMed ID: 10021804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary and secondary prevention of ischemic stroke].
    Awada A
    J Med Liban; 2011; 59(4):213-9. PubMed ID: 22746010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cautionary note on data sources for evidence-based clinical decisions: warfarin and stroke prevention.
    Thomson R; Eccles M; Wood R; Chinn DJ
    Med Decis Making; 2007; 27(4):438-47. PubMed ID: 17641140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.